Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Mesothelioma Cancer treatment details. Chemotherapy. Erasmus Medical Center, Rotterdam, Netherlands



Survival: 8.2 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs: Temodar
Country: Netherlands
   
City/State/Province: Rotterdam
   
Hospital: Erasmus Medical Center
   
Journal: Link
   
Date: 4/2002

Description:
Patients: This Phase II study involved 27 patients with malignant pleural mesothelioma. None of these patients had been administered prior chemotherapy.

Treatment: The treatment consisted of the chemotherapy drug, temozolomide (temodar).

Toxicity: Grade 3-4 toxicities included hematologic, infection, nausea, vomiting, and arthralgia.

Results: The median overall survival from the time the patient registered in the study was 8.2 months.

Support: Schering-Plough International supported this study. Schering-Plough markets temodar.

Correspondence: J.P. van Meerbeeck

E-mail to a Friend Email Physician More Information